Abiopharma

New Form 8-K - RxSight, Inc. Filed: 2025-08-04 AccNo: 0000950170-25-102065 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-04 AccNo: 0001437749-25-024625 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019963 Size: 5 KB

New Form 8-K - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-04 AccNo: 0001193125-25-172653 Size: 157 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form SCHEDULE 13G - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002868 Size: 11 KB

New Form 4 - Pacira BioSciences, Inc. Filed: 2025-08-04 AccNo: 0001396814-25-000095 Size: 5 KB

New Form 4 - Cencora, Inc. Filed: 2025-08-04 AccNo: 0001986505-25-000005 Size: 4 KB

New Form SCHEDULE 13G/A - ClearPoint Neuro, Inc. Filed: 2025-08-04 AccNo: 0000921895-25-002077 Size: 20 KB

New Form 6-K - Cellectis S.A. Filed: 2025-08-04 AccNo: 0000950170-25-102055 Size: 3 MB

New Form SCHEDULE 13G/A - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002867 Size: 11 KB

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019958 Size: 5 KB

HealthStream Announces Second Quarter 2025 Results